Join        Login             Stock Quote

Reshuffling the Lineup for the Health Care Model

 November 27, 2012 11:00 AM

Before commenting on the month of October in the Healthcare model on Covestor, let me wish all of my friends affected by the disastrous Hurricane Sandy a speedy recovery. Times like these force us to examine our priorities and sometimes our investment performance isn't as significant as the welfare of our own families and friends.

The month of October was a difficult month for the Healthcare model, except for Schiff (SHF) which on October 30th became an acquisition target of German drug and chemical maker Bayer AG (BAYRY) for $1.2 billion or $34 per share.

[Related -Express Scripts Holding Company (ESRX): Should You Own ESRX in 2014?]

I spent much of the month selling off many of my holdings on what appeared to be growing weakness in the market, the sector, and in the individual stocks held. Align Technologies (ALGN) sold October 18th, Alexion (ALXN) was sold October 24th, Biogen Idec (BIIB) was sold October 31st, Express Scripts (ESRX) was sold October 19th, HMS Holdings (HMSY) was sold October 4th, and  Healthstream (HSTM) was sold October 23rd.

[Related -Amgen, Inc. (NASDAQ:AMGN): What Will Drive Amgen This Year?]

In addition, the Medicines Company (MDCO) was sold October 5th. Regeneron (REGN) was purchased October 15th,  and then sold October 23rd on technical weakness. Finally, ResMed (RMD), another long-term favorite, and a holding in my Sustained Momentum model, was purchased October 24th, only to be sold on October 26th.

During the month, the only new holding that made it through this correction was Davita (DVA), which was purchased October 11th. DaVita operates a chain of kidney dialysis centers.

At the end of the month, the remaining holdings in the model consisted of Abbott Laboratories (ABT), Amgen (AMGN), DaVita (DVA), IDEXX Laboratories (IDXX), Lilly (LLY), Perrigo (PRGO), and Schiff (SHF).

I shall continue to search for new opportunities to put this growing cash position to work. However, the weakness in many of these holdings has led me to part company. Indeed, being aware that others besides myself may be following my lead, as is the case on Covestor, adds an additional emphasis on avoiding losses while looking for stocks that may offer all of us reasonable gains.

The investments discussed are held in client accounts as of October 31, 2012. These investments may or may not be currently held in client accounts. The reader should not assume that any investments identified were or will be profitable or that any investment recommendations or that investment decisions we make in the future will be profitable.

Certain of the information contained in this presentation is based upon forward-looking statements, information and opinions, including descriptions of anticipated market changes and expectations of future activity. The manager believes that such statements, information, and opinions are based upon reasonable estimates and assumptions. However, forward-looking statements, information and opinions are inherently uncertain and actual events or results may differ materially from those reflected in the forward-looking statements. Therefore, undue reliance should not be placed on such forward-looking statements, information and opinions.

Covestor Ltd. is a registered investment advisor. Covestor licenses investment strategies from its Model Managers to establish investment models. The commentary here is provided as general and impersonal information and should not be construed as recommendations or advice. Information from Model Managers and third-party sources deemed to be reliable but not guaranteed. Past performance is no guarantee of future results. Transaction histories for Covestor models available upon request. Additional important disclosures available at http://site.covestor.com/help/disclosures. For information about Covestor and its services, go to http://covestor.com or contact Covestor Client Services at (866) 825-3005, x703.

Robert Freedland

Robert has over 40 years of investment experience and is a full-time optical surgeon.



Post Comment -- Login is required to post message
Alert for new comments:
Your email:
Your Website:

rss feed

Latest Stories

article imageAutomating Ourselves To Unemployment

In this current era of central planning, malincentives abound. We raced to frack as fast we could for the read on...

article imageFed: Waiting For June… Or Godot?

The Federal Reserve left interest rates unchanged yesterday, as widely expected. But the possibility of a read on...

article imageThe Single Best Place To Invest Your Money For Retirement

It was never supposed to be this daunting. At least that's what we were read on...

article imageNegative Blowback From Negative Interest Rates

The Federal Reserve is widely expected to leave interest rates unchanged today. But perhaps standing pat read on...

Popular Articles

Daily Sector Scan
Partner Center

Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.